Moreover, we found considerable PMCA4b upregulation during HDAC inhibitor treatment of MCF-7 breast cancer cells, and this effect was further enhanced by phorbol 12-myristate 13-acetate (PMA). This evidence concerns the gene ATP2B4 and breast cancer.